The DOI matches its Crossref record; 379 of the 379 references it cites were found in a registry or an index.
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
Open accessAbstract
Introduction: Breast cancer remains a significant scientific, clinical and societal challenge. This gap analysis has reviewed and critically assessed enduring issues and new challenges emerging from recent research, and proposes strategies for translating solutions into practice. Methods: More than 100 internationally recognised specialist breast cancer scientists, clinicians and healthcare professionals collaborated to address nine thematic areas: genetics, epigenetics and epidemiology; molecular pathology and cell biology; hormonal influences and endocrine therapy; imaging, detection and screening; current/novel therapies and biomarkers; drug resistance; metastasis, angiogenesis, circulating tumour cells, cancer ‘stem’ cells; risk and prevention; living with and managing breast cancer and its treatment. The groups developed summary papers through an iterative process which, following further appraisal from experts and patients, were melded into this summary account. Results: The 10 major gaps identified were: (1) understanding the functions and contextual interactions of genetic and epigenetic changes in normal breast development and during malignant transformation; (2) how to implement sustainable lifestyle changes (diet, exercise and weight) and chemopreventive strategies; (3) the need for tailored screening approaches including clinically actionable tests; (4) enhancing knowledge of molecular drivers behind breast cancer subtypes, progression and metastasis; (5) understanding the molecular mechanisms of tumour heterogeneity, dormancy, de novo or acquired resistance and how to target key nodes in these dynamic processes; (6) developing validated markers for chemosensitivity and radiosensitivity; (7) understanding the optimal duration, sequencing and rational combinations of treatment for improved personalised therapy; (8) validating multimodality imaging biomarkers for minimally invasive diagnosis and monitoring of responses in primary and metastatic disease; (9) developing interventions and support to improve the survivorship experience; (10) a continuing need for clinical material for translational research derived from normal breast, blood, primary, relapsed, metastatic and drug-resistant cancers with expert bioinformatics support to maximise its utility. The proposed infrastructural enablers include enhanced resources to support clinically relevant in vitro and in vivo tumour models; improved access to appropriate, fully annotated clinical samples; extended biomarker discovery, validation and standardisation; and facilitated cross-discipline working. Conclusions: With resources to conduct further high-quality targeted research focusing on the gaps identified, increased knowledge translating into improved clinical care should be achievable within five years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–379 of 379
Emerging targeted agents in metastatic breast cancer
Zardavas, D., Baselga, J., & Piccart, M. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.29 · Cited by 178
Early and late cognitive changes following temporal lobe surgery for epilepsy
Rausch, R., Kraemer, S., Pietras, C. J., Le, M., Vickrey, B. G., & Passaro, E. A. (2003) · Neurology · doi:10.1212/01.wnl.0000048203.23766.a1 · Cited by 177
Amir, E., Clemons, M., Purdie, C. A., Miller, N., Quinlan, P., Geddie, W., Coleman, R. E., Freedman, O. C., Jordan, L. B., & Thompson, A. M. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.006 · Cited by 176
Self-citationAntoniou, A. C., Beesley, J., McGuffog, L., Sinilnikova, O. M., Healey, S., Neuhausen, S. L., Ding, Y. C., Rebbeck, T. R., Weitzel, J. N., Lynch, H. T., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1907 · Cited by 176
Self-citationCirculating tumour cells and cell-free DNA as tools for managing breast cancer
De Mattos-Arruda, L., Cortes, J., Santarpia, L., Vivancos, A., Tabernero, J., Reis-Filho, J. S., & Seoane, J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.80 · Cited by 174
Martinez-Outschoorn, U. E., Goldberg, A. F., Lin, Z., Ko, Y.-H., Flomenberg, N., Wang, C., Pavlides, S., Pestell, R. G., Howell, A., Sotgia, F., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.10.17780 · Cited by 174
Self-citationBreast-cancer stem cells—beyond semantics
Badve, S., & Nakshatri, H. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70191-7 · Cited by 174
Use of Reprogrammed Cells to Identify Therapy for Respiratory Papillomatosis
Yuan, H., Myers, S., Wang, J., Zhou, D., Woo, J. A., Kallakury, B., Ju, A., Bazylewicz, M., Carter, Y. M., Albanese, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203055 · Cited by 169
Swerdlow, A. J., Cooke, R., Bates, A., Cunningham, D., Falk, S. J., Gilson, D., Hancock, B. W., Harris, S. J., Horwich, A., Hoskin, P. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.8835 · Cited by 169
Drasin, D. J., Robin, T. P., & Ford, H. L. (2011) · Breast Cancer Research · doi:10.1186/bcr3037 · Cited by 168
de Visser, K. E., Ciampricotti, M., Michalak, E. M., Tan, D. W., Speksnijder, E. N., Hau, C., Clevers, H. C., Barker, N., & Jonkers, J. (2012) · The Journal of Pathology · doi:10.1002/path.4096 · Cited by 167
Pontiggia, O., Sampayo, R., Raffo, D., Motter, A., Xu, R., Bissell, M. J., de Kier Joffé, E. B., & Simian, M. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1766-x · Cited by 166
Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up
Gielissen, M. F. M., Verhagen, C. A. H. H. V. M., & Bleijenberg, G. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603899 · Cited by 166
Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer
Wei, S., Liu, L., Zhang, J., Bowers, J., Gowda, G. A. N., Seeger, H., Fehm, T. N., Neubauer, H. J., Vogel, U. F., Clare, S. E., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.003 · Cited by 164
Palmieri, D., Lockman, P. R., Thomas, F. C., Hua, E., Herring, J., Hargrave, E., Johnson, M., Flores, N., Qian, Y., Vega-Valle, E., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1039 · Cited by 164
Self-citationIntragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk
Brennan, K., García‐Closas, M., Orr, N., Fletcher, O., Jones, M. E., Ashworth, A., Swerdlow, A. J., Thorne, H., Ríboli, E., Vineis, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3157 · Cited by 164
Self-citationThe complex genetic landscape of familial breast cancer
Melchor, L., & Benítez, J. (2013) · Human Genetics · doi:10.1007/s00439-013-1299-y · Cited by 163
Louie, E., Nik, S., Chen, J., Schmidt, M. M., Song, B., Pacson, C., Chen, X. F., Park, S.-H. E., Ju, J., & Chen, E. I. (2010) · Breast Cancer Research · doi:10.1186/bcr2773 · Cited by 162
Review of exercise studies in breast cancer survivors: attention to principles of exercise training
Campbell, K. L., Neil‐Sztramko, S., & Winters‐Stone, K. M. (2012) · British Journal of Sports Medicine · doi:10.1136/bjsports-2010-082719 · Cited by 161
Targeting the Metabolic Microenvironment of Tumors
Bailey, K. M., Wojtkowiak, J. W., Hashim, A. I., & Gillies, R. J. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00004-x · Cited by 160
Quantifying heterogeneity in human tumours using MRI and PET
Asselin, M., O’Connor, J. P. B., Boellaard, R., Thacker, N. A., & Jackson, A. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.025 · Cited by 160
Self-citationLoss of Par3 promotes breast cancer metastasis by compromising cell–cell cohesion
Xue, B., Krishnamurthy, K., Allred, D. C., & Muthuswamy, S. K. (2013) · Nature Cell Biology · doi:10.1038/ncb2663 · Cited by 159
Screening for Psychological Distress in Cancer Patients: Challenges and Opportunities
Jacobsen, P. B. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1367 · Cited by 159
Hannoun‐Lévi, J., Resch, A., Gal, J., Kauer-Dorner, D., Strnad, V., Niehoff, P., Loessl, K., Kovács, G., Limbergen, E. V., & Polgár, C. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.03.026 · Cited by 158
Li, C. I., Chlebowski, R. T., Freiberg, M. S., Johnson, K., Kuller, L. H., Lane, D. S., Lessin, L. S., O’Sullivan, M. J., Wactawski‐Wende, J., Yasmeen, S., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq316 · Cited by 157
Gomes, F. G., Nedel, F., Alves, A. M., Nor, J. E., & Tarquínio, S. B. C. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.10.008 · Cited by 155
Sarrió, D., Franklin, C. K., Mackay, A. G., Reis-Filho, J. S., & Isacke, C. M. (2011) · Stem Cells · doi:10.1002/stem.791 · Cited by 153
Azim, H. A., Michiels, S., Zagouri, F., Delaloge, S., Filipits, M., Namer, M., Neven, P., Symmans, W. F., Thompson, A. M., André, F., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds645 · Cited by 145
Self-citationCorner, J. L., Wright, D., Hopkinson, J. B., Gunaratnam, Y., McDonald, J. W., & Foster, C. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603662 · Cited by 144
Self-citationCommon Molecular Mechanisms of Mammary Gland Development and Breast Cancer
Lundgren, K., Holm, C., & Landberg, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7390-6 · Cited by 142
Kabos, P., Finlay-Schultz, J., Li, C., Kline, E. C., Finlayson, C. A., Wisell, J. A., Manuel, C. A., Edgerton, S. M., Harrell, J. C., ELIAS, A. D., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2164-8 · Cited by 139
Giamas, G., Filipović, A., Jacob, J., Messier, W., Zhang, H., Yang, D., Zhang, W., Shifa, B. A., Photiou, A., Tralau-Stewart, C. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2351 · Cited by 139
Self-citationMannino, M., & Yarnold, J. R. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.05.002 · Cited by 138
Taking CHARGE: a self-management program for women following breast cancer treatment
Cimprich, B., Janz, N. K., Northouse, L., Wren, P. A., Given, B., & Given, C. W. (2005) · Psycho-Oncology · doi:10.1002/pon.891 · Cited by 134
Evaluation of the current knowledge limitations in breast cancer research: a gap analysis
Thompson, A. M., Brennan, K. R., Cox, A., Gee, J. M. W., Harcourt, D. M., Harris, A. L., Harvie, M., Holen, I., Howell, A., Nicholson, R. I., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr1983 · Cited by 125
Self-citationEvans, D. G., Warwick, J., Astley, S., Stavrinos, P., Sahin, S., Ingham, S. L., McBurney, H., Eckersley, B., Harvie, M., Wilson, M., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0458 · Cited by 125
Self-citationHulbert-Williams, N., Neal, R. D., Morrison, V. L., Hood, K., & Wilkinson, C. (2011) · Psycho-Oncology · doi:10.1002/pon.1980 · Cited by 125
Self-citationArmes, J., Chalder, T., Addington-Hall, J. M., Richardson, A., & Hotopf, M. H. (2007) · Cancer · doi:10.1002/cncr.22923 · Cited by 124
Self-citationRethinking the metastatic cascade as a therapeutic target
Mina, L. A., & Sledge, G. W. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.59 · Cited by 123
Darabi, H., Czene, K., Zhao, W., Liu, J., Hall, P. N., & Humphreys, K. (2012) · Breast Cancer Research · doi:10.1186/bcr3110 · Cited by 123
Chui, M. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27745 · Cited by 122
Lifestyle and Breast Cancer Recurrences: The DIANA-5 Trial
Villarini, A., Pasanisi, P., Traina, A., Mano, M. P., Bonanni, B., Panico, S., Scipioni, C., Galasso, R., Paduos, A., Simeoni, M., et al. (2012) · Tumori Journal · doi:10.1177/030089161209800101 · Cited by 121
Stanton, A. L., Luecken, L. J., MacKinnon, D. P., & Thompson, E. H. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0028833 · Cited by 114 · cited 1×
“Some interventions have demonstrated benefit with specific side effects [329-331].”
Psychiatric disorder in patients with advanced breast cancer: Prevalence and associated factors
Ramirez, A. J., Pinder, K. L., Black, M. E., Richards, M., Gregory, W. M., & Rubens, R. D. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80144-3 · Cited by 112
Farhat, G. N., Cummings, S. R., Chlebowski, R. T., Parimi, N., Cauley, J. A., Rohan, T. E., Huang, A. J., Vitolins, M. Z., Hubbell, F. A., Manson, J. E., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr031 · Cited by 108
Personalised cancer follow-up: risk stratification, needs assessment or both?
Watson, E. K., Rose, P. W., Neal, R. D., Hulbert-Williams, N., Donnelly, P., Hubbard, G., Elliott, J., Campbell, C., Weller, D., & Wilkinson, C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.535 · Cited by 106 · cited 1×
“The long-term impacts of breast cancer and therapy on everyday life need further investigation [351].”
Self-citationCapala, J., & Bouchelouche, K. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32833f8c3a · Cited by 106
Androgen receptor as a targeted therapy for breast cancer.
Garay, J. P., & Park, B. H. (2012) · Europe PMC (PubMed Central) · Cited by 105
Richardson, A. M., Addington-Hall, J. M., Amir, Z., Foster, C. L., Stark, D., Armes, J., Brearley, S. G., Hodges, L., Hook, J., Jarrett, N., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.425 · Cited by 104
Self-citationMetabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery
Denkert, C., Bucher, E., Hilvo, M., Salek, R. M., Orešič, M., Griffin, J. L., Brockmöller, S. F., Klauschen, F., Loibl, S., Barupal, D. K., et al. (2012) · Genome Medicine · doi:10.1186/gm336 · Cited by 101
Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
Sultana, R., Abdel-Fatah, T. M. A., Abbotts, R., Hawkes, C., Albarakati, N., Seedhouse, C., Ball, G., Chan, S. Y. T., Rakha, E. A., Ellis, I. O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2929 · Cited by 100
Self-citationSanten, R. J., Fan, P., Zhang, Z., Bao, Y., Song, R. X.-D., & Yue, W. (2008) · Steroids · doi:10.1016/j.steroids.2008.11.020 · Cited by 99
Lindor, N. M., Goldgar, D. E., Tavtigian, S. V., Plon, S. E., & Couch, F. J. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0452 · Cited by 99
Rutgers, E. J. T., Donker, M., Straver, M. E., Meijnen, P., van de Velde, C. J. �., Mansel, R. E., Westenberg, H., Orzalesi, L., Bouma, W. H., van der Mijle, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.lba1001 · Cited by 98
Chen, Y., Chen, Y., Ross, D. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017876 · Cited by 98
Cell communication networks in cancer invasion
Calvo, F., & Sahai, E. A. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.04.010 · Cited by 98
Self-citationFourie, W. J., & Robb, K. A. (2009) · Physiotherapy · doi:10.1016/j.physio.2009.05.001 · Cited by 97
Mutrie, N., Campbell, A., Barry, S., Hefferon, K., McConnachie, A., Ritchie, D., & Tovey, S. (2012) · Journal of Cancer Survivorship · doi:10.1007/s11764-012-0233-y · Cited by 95
Self-citationAdvanced Breast Cancer Patients' Perceptions of Decision Making for Palliative Chemotherapy
Grunfeld, E. A., Maher, E. J., Browne, S., Ward, P., Young, T., Vivat, B., Walker, G., Wilson, C. J., POTTS, H. W. W., Westcombe, A. M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.9208 · Cited by 94
Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management
(WINS), F. T. W. I. N. S., Chlebowski, R. T., Rose, D. P., Buzzard, I. M., Blackburn, G. L., Insull, W., Grosvenor, M. B., Elashoff, R. M., & Wynder, E. L. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01834637 · Cited by 93
Inhibition of Breast Cancer Metastases by a Novel Inhibitor of TGFβ Receptor 1
Fang, Y., Chen, Y., Yu, L., Zheng, C., Ya, Q., Li, Z., Yang, Z., Zhang, Y., Shi, T., Luo, J., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs485 · Cited by 92
Tenori, L., Oakman, C. A., Claudino, W. M., Bernini, P., Cappadona, S., Nepi, S., Biganzoli, L., Arbushites, M. C., Luchinat, C., Bertini, I., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.05.003 · Cited by 91
Gene expression and hypoxia in breast cancer
Favaro, E., Lord, S., Harris, A. L., & Buffa, F. M. (2011) · Genome Medicine · doi:10.1186/gm271 · Cited by 91
Poor prognosis in elderly patients with cancer: the role of bias and undertreatment.
Dale, D. C. (2003) · PubMed · Cited by 90
Cancer genetic risk assessment for individuals at risk of familial breast cancer
Hilgart, J., Coles, B., & Iredale, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003721.pub3 · Cited by 90
Reed, E., Simmonds, P., Haviland, J., & Corner, J. L. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.05.005 · Cited by 90
Self-citationMolecular hierarchy of mammary differentiation yields refined markers of mammary stem cells
dos Santos, C. O., Rebbeck, C. A., Rozhkova, E., Valentine, A., Samuels, A., Kadiri, L. R., Osten, P., Harris, E. Y., Uren, P. J., Smith, A. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303919110 · Cited by 90
Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women
Key, T. J. (2011) · Steroids · doi:10.1016/j.steroids.2011.02.029 · Cited by 89
Self-citationHypoxia/reoxygenation: A dynamic regulator of lysyl oxidase‐facilitated breast cancer migration
Postovit, L.-M. M., Abbott, D. E., Raimondi, S. L., Wheaton, W. W., Margaryan, N. V., Sullivan, R., Jansen, M. K., Csiszár, K., Hendrix, M. J. C., & Kirschmann, D. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21517 · Cited by 88
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up
Foster, C., Watson, M., Eeles, R., Eccles, D., Ashley, S., Davidson, R., Mackay, J., Morrison, P., Hopwood, P., & Evans, D. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603610 · Cited by 87
Self-citationThompson, A. M., Johnson, A., Quinlan, P., Hillman, G. R., Fontecha, M., Bray, S. E., Purdie, C. A., Jordan, L. B., Ferraldeschi, R., Latif, A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1139-x · Cited by 87
Self-citationGuérin, É., Man, S., Xu, P., & Kerbel, R. S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4183 · Cited by 86
Bloom, J. R., STEWART, S. L., D’Onofrio, C. N., Luce, J. A., & Banks, P. J. (2008) · Journal of Cancer Survivorship · doi:10.1007/s11764-008-0058-x · Cited by 86
Wakefield, C. E., Meiser, B., Homewood, J., Peate, M., Taylor, A., Lobb, E. A., Kirk, J., Young, M., Williams, R., Dudding, T. E., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9539-2 · Cited by 83
Stem cells in breast tumours: Are they ready for the clinic?
Ablett, M. P., Singh, J. K., & Clarke, R. B. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.019 · Cited by 83
Self-citationSteeg, P. S. (2012) · Nature · doi:10.1038/485s58a · Cited by 82
Physical Examination of the Abdomen in Health and Disease. Part First
Williams, C. J. B. (1851) · BMJ · doi:10.1136/bmj.s2-3.25.1 · Cited by 81
The German SUCCESS C Study – The First European Lifestyle Study on Breast Cancer
Rack, B. K., Andergassen, U., Neugebauer, J. K., Salmen, J., Hepp, P. G., Sommer, H. L., Lichtenegger, W., Friese, K., Beckmann, M. W., Hauner, D., et al. (2010) · Breast Care · doi:10.1159/000322677 · Cited by 81
Wong, A. L., & Lee, S. C. (2012) · International Journal of Breast Cancer · doi:10.1155/2012/415170 · Cited by 80
Exosome signaling in mammary gland development and cancer
Hendrix, A., & Hume, A. N. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113391ah · Cited by 79
The Tumor Microenvironment: A Target for Combination therapy of Breast Cancer
Reisfeld, R. A. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.70 · Cited by 78
Targeting tumour hypoxia in breast cancer
Milani, M., & Harris, A. L. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.09.025 · Cited by 78
Borowsky, A. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009670 · Cited by 78
Speck, R. M., Courneya, K. S., Mâsse, L. C., Duval, S., & Schmitz, K. H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0137-7 · Cited by 78
Changing End Points in Breast-Cancer Drug Approval — The Avastin Story
D’Agostino, R. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1106984 · Cited by 77
Breast cancer stem cells: Obstacles to therapy
Smalley, M. J., Piggott, L., & Clarkson, R. W. E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.023 · Cited by 76
Self-citationLipkus, I. M., Peters, E. M., Kimmick, G. G., Liotcheva, V. B., & Marcom, P. K. (2010) · Medical Decision Making · doi:10.1177/0272989x09360371 · Cited by 75
Qualification of imaging biomarkers for oncology drug development
Waterton, J. C., & Pylkkänen, L. H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.037 · Cited by 74
Moulder, S. L., Moroney, J. W., Helgason, T., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0604 · Cited by 74
Courneya, K. S., Karvinen, K. H., McNeely, M. L., et al. (2012) · Journal of Physical Activity and Health · doi:10.1123/jpah.9.6.857 · Cited by 74
Value and Limitations of Measuring HER-2 Extracellular Domain in the Serum of Breast Cancer Patients
Leary, A. F., Hanna, W. M., van de Vijver, M. J., Penault-Llorca, F. M., Rüschoff, J., OSAMURA, R. Y., Bilous, M., & Dowsett, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3989 · Cited by 74
Follow-up care for cancer survivors: views of the younger adult
on behalf of the Late Effects Group, S., Absolom, K. L., Eiser, C., Michel, G., Walters, S. J., Hancock, B. W., Coleman, R. E., Snowden, J. A., & Greenfield, D. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605213 · Cited by 73
Turabi, A. E., Abel, G., Roland, M. O., & Lyratzopoulos, G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.316 · Cited by 73
Turning of COGS moves forward findings for hormonally mediated cancers
Sakoda, L. C., Jorgenson, E., & Witte, J. S. (2013) · Nature Genetics · doi:10.1038/ng.2587 · Cited by 72
Fontein, D. B. Y., Seynaeve, C., Hadji, P., Hille, E. T. M., van de Water, W., Putter, H., Kranenbarg, E. M., Hasenburg, A., Paridaens, R., Vannetzel, J.-M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3068 · Cited by 71
ROSNER, B. A., Glynn, R. J., Tamimi, R. M., Chen, W. Y., Colditz, G. A., Willett, W. C., & Hankinson, S. E. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws457 · Cited by 71
Randomized Dose-Ranging Trial of Tamoxifen at Low Doses in Hormone Replacement Therapy Users
DeCensi, A., Gandini, S., Serrano, D., Cazzaniga, M., Pizzamiglio, M., Maffini, F. A., Pelosi, G., Daldoss, C., Omodei, U., Johansson, H. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4318 · Cited by 71
Cancer Stem Cells and Tumor Response to Therapy: Current Problems and Future Prospects
Milas, L., & Hittelman, W. N. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.11.004 · Cited by 70
Chemoprevention of Hormone Receptor-Negative Breast Cancer: New Approaches Needed
Uray, I. P., & Brown, P. H. (2010) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-10858-7_13 · Cited by 68
Dietel, M., Jöhrens, K., von Laffert, M., Hummel, M., Bläker, H., Müller, B. M., Lehmann, A., Denkert, C., Heppner, F. L., Koch, A., et al. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.13 · Cited by 68
Lewis, C. E., & Hughes, R. (2007) · Breast Cancer Research · doi:10.1186/bcr1679 · Cited by 68
Krishnan, V., Shuman, L. A., Sosnoski, D. M., Ravi, D., Vogler, E. A., & Mastro, A. M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22550 · Cited by 67
Looking different, feeling different: women’s reactions to risk-reducing breast and ovarian surgery
kConFab Psychosocial Group on behalf of the kConFab Investigators, Hallowell, N., Baylock, B., Heiniger, L., Butow, P. N., Patel, D., Meiser, B., Saunders, C., & Price, M. A. (2012) · Familial Cancer · doi:10.1007/s10689-011-9504-4 · Cited by 66
Tinterri, C., Gatzemeier, W., Zanini, V., et al. (2009) · The Breast · doi:10.1016/j.breast.2009.09.013 · Cited by 66
How integrins control breast biology
Glukhova, M. A., & Streuli, C. H. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.06.010 · Cited by 65
Self-citation(2004) · The Women s Oncology Review · doi:10.1080/14733400500033664 · Cited by 63
Gagnon, B., Mayo, N. E., Hanley, J. A., & Macdonald, N. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.111 · Cited by 62
Anderson, A. S., Mackison, D., Boath, C., & Steele, R. J. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0385 · Cited by 60
Self-citationLelièvre, S. A. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9168-y · Cited by 59
Genetic heterogeneity in breast cancer: the road to personalized medicine?
Baird, R. D., & Caldas, C. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-151 · Cited by 59
Miller, W. R., Larionov, A. A., Anderson, T. J., Evans, D. B., & Dixon, J. M. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.67 · Cited by 55
Self-citationMacaskill, E. J., Bartlett, J. M. S., Sabine, V. S., Faratian, D., Renshaw, L., White, S. L., Campbell, F., Young, O., Williams, L. J., Thomas, J. S. J., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0967-z · Cited by 54
Harder, H., Ballinger, R., Langridge, C., Ring, A. E., & Fallowfield, L. J. (2013) · Psycho-Oncology · doi:10.1002/pon.3338 · Cited by 53
Progress in circulating tumor cell capture and analysis: implications for cancer management
Balić, M., Lin, H., Williams, A. J., Datar, R. H., & Côté, R. J. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.12 · Cited by 53
Gene–gene interactions in breast cancer susceptibility
Turnbull, C., Seal, S., Renwick, A., Warren-Perry, M., Hughes, D., Elliott, A., Pernet, D., Peock, S., Adlard, J., Barwell, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr525 · Cited by 53
Self-citationTargeting RANKL in breast cancer: bone metastasis and beyond
Azim, H. A., & Azim, H. A. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.177 · Cited by 50
A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy
Mao, Q., Zhang, Y., Fu, X., Xue, J., Guo, W., Meng, M., Zhou, Z., Mo, X., & Lü, Y. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1310-3 · Cited by 50
Stem Cells and the Developing Mammary Gland
Makarem, M., Spike, B. T., Dravis, C., Kannan, N., Wahl, G. M., & Eaves, C. J. (2013) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-013-9284-6 · Cited by 49
Polarity proteins as regulators of cell junction complexes: Implications for breast cancer
Bazzoun, D., Lelièvre, S. A., & Talhouk, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.02.004 · Cited by 49
Age and the effect of physical activity on breast cancer survival: A systematic review
Fontein, D. B. Y., de Glas, N. A., Duijm, M., Bastiaannet, E., Portielje, J. E. A., van de Velde, C. J. �., & Liefers, G. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.008 · Cited by 49
Mann, E., Smith, M. J., Hellier, J. M., & Hunter, M. S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-44 · Cited by 47
Self-citationFenlon, D., Corner, J. L., & Haviland, J. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.05.014 · Cited by 47
Self-citationMolyneux, G., & Smalley, M. J. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9202-8 · Cited by 47
Self-citationWilson, C., Holen, I., & Coleman, R. E. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.02.007 · Cited by 46
Self-citationLymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread
Ferris, R. L., Lotze, M. T., Leong, S. P. L., Hoon, D. S. �., & Morton, D. L. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9520-2 · Cited by 46
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial
Witzel, I., Loibl, S., von Minckwitz, G., Mundhenke, C., Huober, J., Hanusch, C. A., Henschen, S., Hauschild, M., Lantzsch, T., Tesch, H., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1030-9 · Cited by 46
Criscitiello, C., Azim, H. A., Agbor‐Tarh, D., de Azambuja, E., Piccart, M. J., Baselga, J. M., Eidtmann, H., Cosimo, S. D., Bradbury, I., & Rubio, I. T. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt129 · Cited by 46
Comen, E. A., & Norton, L. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-28160-0_2 · Cited by 45
Living into old age with the consequences of breast cancer
Fenlon, D., Frankland, J., Foster, C. L., et al. (2012) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2012.08.004 · Cited by 45
Self-citationHo, K., Poon, P. C., Owen, S. C., & Shoichet, M. S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-579 · Cited by 45
Thoughts about cancer stem cells in solid tumors
Porta, C. A. M. L. (2012) · World Journal of Stem Cells · doi:10.4252/wjsc.v4.i3.17 · Cited by 44
How can grafted breast cancer models be optimized?
Mollard, S., Mousseau, Y., Baaj, Y., Richard, L., Cook‐Moreau, J., Monteil, J., Funalot, B., & Sturtz, F. G. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.10.18139 · Cited by 44
Carlson, R. W., O’Neill, A., Vidaurre, T., Gómez, H., Badve, S., & Sledge, G. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1997-5 · Cited by 43
Teras, L. R., Goodman, M. G., Patel, A. V., Diver, W. R., Flanders, W. D., & Feigelson, H. S. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9730-y · Cited by 42
FDA committee votes to withdraw bevacizumab for breast cancer
Lenzer, J. (2011) · BMJ · doi:10.1136/bmj.d4244 · Cited by 42
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model
Dite, G. S., Mahmoodi, M. S., Bickerstaffe, A., Hammet, F., MacInnis, R. J., Tsimiklis, H., Dowty, J. G., Apicella, C., Phillips, K., Giles, G. G., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2610-2 · Cited by 42
Hamilton-Burke, W., Coleman, L., Cummings, M., Green, C. A., Holliday, D. L., Horgan, K. J., Maraqa, L., Peter, M. B., Pollock, S., Shaaban, A. M., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090886 · Cited by 42
Self-citationOliveri, J. M., Day, J. M., Alfano, C. M., Herndon, J. E., Katz, M. L., Bittoni, M. A., Donohue, K., & Paskett, E. D. (2008) · Journal of Cancer Survivorship · doi:10.1007/s11764-008-0065-y · Cited by 41
ABC of Breast Diseases: Psychological aspects
Maguire, P. (1994) · BMJ · doi:10.1136/bmj.309.6969.1649 · Cited by 41
Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients
Giordano, A., Gao, H., Cohen, E. N., Anfossi, S., Khoury, J. D., Hess, K. R., Krishnamurthy, S., Tin, S., Cristofanilli, M., Hortobágyi, G. N., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt223 · Cited by 39
Marchini, C., Montani, M., Konstantinidou, G., Orrù, R., Mannucci, S., Ramadori, G., Gabrielli, F., Baruzzi, A., Berton, G., Merigo, F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014131 · Cited by 38
Karamouzis, M. V., IOANNIDIS, G., & Rigatos, G. (2007) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2006.00771.x · Cited by 38
Kerbel, R. S. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9266-0 · Cited by 35
Breast cancer subtyping from plasma proteins
Zhang, F., & Chen, J. Y. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s1-s6 · Cited by 35
Translating Genomics to the Clinic: Implications of Cancer Heterogeneity
Samuel, N., & Hudson, T. J. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.184580 · Cited by 35
Menopausal hot flushes after breast cancer
Fenlon, D., Corner, J. L., & Haviland, J. (2009) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2007.00902.x · Cited by 35
Self-citationHypoxia and Metastasis in Breast Cancer
Rundqvist, H., & Johnson, R. S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_77 · Cited by 34
Intermittent supplementation with rapamycin as a dietary restriction mimetic
Longo, V. D., & Fontana, L. (2011) · Aging · doi:10.18632/aging.100401 · Cited by 34
Adams, S., Greeder, L., Reich, E. W., Shao, Y., Fosina, D., Hanson, N. C., Tassello, J., Singh, B., Spagnoli, G. C., Demaria, S., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1005-7 · Cited by 32
for the TFGT Collaborative Group, Watts, K., Meiser, B., Mitchell, G., Kirk, J., Saunders, C. M., Peate, M., Duffy, J., Kelly, P. J., Gleeson, M., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-320 · Cited by 31
Denosumab in breast cancer treatment
Drooger, J. C., van der Padt, A., Sleijfer, S., & Jager, A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.034 · Cited by 30
Bisphosphonates: Prevention of Bone Metastases in Breast Cancer
Gnant, M., Dubsky, P. C., & Hadji, P. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-21892-7_3 · Cited by 30
Dunn, B. K., Jegalian, K., & Greenwald, P. (2010) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-10858-7_3 · Cited by 29
Fan, P., Yue, W., Wang, J.-P., Aiyar, S. E., Li, Y., Kim, T. H., & Santen, R. J. (2009) · Endocrinology · doi:10.1210/en.2008-1195 · Cited by 29
Andrechek, E. R., & Nevins, J. R. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0644-z · Cited by 27
Coates, P. J., Virginia, M., Appleyard, C. L., Murray, K. E., Ackland, C., Gardner, J., Brown, D. C., Adamson, D. J. A., Jordan, L. B., Purdie, C. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1118 · Cited by 27
Self-citationDiabetes, Metformin, and Breast Cancer: Lilac Time?
Goodwin, P. J., Thompson, A. M., & Stambolic, V. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.3319 · Cited by 26
Self-citationOvercoming endocrine resistance in breast cancer: importance of mTOR inhibition
Gnant, M. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.138 · Cited by 25
Capozzo, M. A., Martinis, E., Pellis, G., & Giraldi, T. (2010) · Cancer Nursing · doi:10.1097/ncc.0b013e3181c1acd6 · Cited by 25
(2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976117 · Cited by 24
Studying Therapy Response and Resistance in Mouse Models for BRCA1-Deficient Breast Cancer
Michalak, E. M., & Jonkers, J. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9199-z · Cited by 23
Psychological adjustment among partners of women at high risk of developing breast/ovarian cancer
Mireskandari, S., Sherman, K. A., Meiser, B., Taylor, A., Gleeson, M., Andrews, L., & Tucker, K. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e3180534293 · Cited by 21
Watts, K., Meiser, B., Conlon, H. A., Rovelli, S., Tiller, K., Zorbas, H. M., Lewis, C. R., Neil, G., & Friedlander, M. L. (2011) · Oncology nursing forum · doi:10.1188/11.onf.627-631 · Cited by 18
Current Controversies in Breast Cancer Surgery
Critchley, A. C., Thompson, A. M., Chan, H.-Y., & Reed, M. (2012) · Clinical Oncology · doi:10.1016/j.clon.2012.10.009 · Cited by 18
Self-citationKelly, C. M., & Buzdar, A. U. (2013) · Drugs · doi:10.1007/s40265-013-0044-0 · Cited by 17
Mammary gland stem cells: More puzzles than explanations
Kaimala, S., Bisana, S., & Kumar, S. (2012) · Journal of Biosciences · doi:10.1007/s12038-012-9200-z · Cited by 15
Elsberger, B., Paravasthu, D. M., Tovey, S., & Edwards, J. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1096-8 · Cited by 15
Self-citationPalmieri, C., Shah, D., Krell, J., Gojiš, O., Hogben, K. R., Riddle, P., Ahmad, R., Tat, T., Fox, K. F., Porter, A. W., et al. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.03.001 · Cited by 15
Self-citationBreast cancer metastasis: when, where, how?
Eccles, S. A., & Paon, L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74204-5 · Cited by 15
Self-citationA Unique 3D In Vitro Cellular Invasion Assay
Quail, D. F., Maciel, T. J., Rogers, K. A., & Postovit, L.-M. M. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112449863 · Cited by 14
Emilsson, S., Svensk, A.-C., Tavelin, B., & Lindh, J. (2012) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2012.01343.x · Cited by 13
What Can Be Learnt about Disease Progression in Breast Cancer Dormancy from Relapse Data?
Willis, L., Graham, T. A., Alarcón, T., Alison, M. R., Tomlinson, I. P. M., & Page, K. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062320 · Cited by 13
Ingham, S. L., Warwick, J., Byers, H., Lalloo, F. I., Newman, W. G., & Evans, D. G. (2012) · Clinical Genetics · doi:10.1111/cge.12035 · Cited by 12
Self-citationCritical choices for modeling breast cancer in transgenic mouse models
Caligiuri, I., Rizzolio, F., Boffo, S., Giordano, A., & Toffoli, G. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.24031 · Cited by 12
Eradication of breast cancer cells in patients with distant metastasis: the finishing touches?
Ito, Y., Iwase, T., & Hatake, K. (2011) · Breast Cancer · doi:10.1007/s12282-011-0266-5 · Cited by 11
Albada, A., Werrett, J., van Dulmen, S., Bensing, J. M., Chapman, C. J., Ausems, M. G. E. M., & Metcalfe, A. (2011) · Journal of Community Genetics · doi:10.1007/s12687-011-0061-1 · Cited by 11
Transgenic mouse models of hormonal mammary carcinogenesis: Advantages and limitations
Kirma, N. B., & TEKMAL, R. R. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.11.005 · Cited by 11
Hubbard, G., Menzies, S., Flynn, P., Adams, S., Haseen, F., Thomas, I., Scanlon, K., Reed, L., & Forbat, L. (2012) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2012-000274 · Cited by 8
Self-citationGrowth Regulatory Pathways Contributing to Organ Selectivity of Metastasis
Eccles, S. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976117.021 · Cited by 3
Self-citation
Cited by
Risk determination and prevention of breast cancer
Howell, A., Anderson, A. S., Clarke, R. B., Duffy, S. W., Evans, D. G., Garcia-Closas, M., Gescher, A. J., Key, T. J., Saxton, J. M., & Harvie, M. N. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0446-2 · Cited by 327
Self-citationTargeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
Kalimutho, M., Parsons, K., Mittal, D., López, J. A., Srihari, S., & Khanna, K. K. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.009 · Cited by 294
Juvet, L. K., Thune, I., Elvsaas, I. K. Ø., Fors, E. A., Lundgren, S., Bertheussen, G., Leivseth, G., & Oldervoll, L. M. (2017) · The Breast · doi:10.1016/j.breast.2017.04.003 · Cited by 288
Saxton, J. M., Scott, E. J., Daley, A. J., Woodroofe, M. N., Mutrie, N., Crank, H., Powers, H. J., & Coleman, R. E. (2014) · Breast Cancer Research · doi:10.1186/bcr3643 · Cited by 111
Self-citationEvans, D. G. R., van Veen, E. M., Byers, H. J., Wallace, A. J., Ellingford, J. M., Beaman, G., Santoyo-Lopez, J., Aitman, T. J., Eccles, D. M., Lalloo, F. I., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.07.002 · Cited by 95
Self-citation
Metadata
- Authors
- Eccles, S. A., Aboagye, E. O., Ali, S., Anderson, A. S., Armes, J., Berditchevski, F., Blaydes, J. P., Brennan, K., Brown, N. J., Bryant, H. E., Bundred, N. J., Burchell, J. M., Campbell, A. M., Carroll, J. S., Clarke, R. B., Coles, C. E., Cook, G. J., Cox, A., Curtin, N. J., Dekker, L. V., dos Santos Silva, I., Duffy, S. W., Easton, D. F., Eccles, D. M., Edwards, D. R., Edwards, J., Evans, D. G., Fenlon, D. F., Flanagan, J. M., Foster, C., Gallagher, W. M., Garcia-Closas, M., Gee, J. M. W., Gescher, A. J., Goh, V., Groves, A. M., Harvey, A. J., Harvie, M., Hennessy, B. T., Hiscox, S., Holen, I., Howell, S. J., Howell, A., Hubbard, G., Hulbert-Williams, N., Hunter, M. S., Jasani, B., Jones, L. J., Key, T. J., Kirwan, C. C., Kong, A., Kunkler, I. H., Langdon, S. P., Leach, M. O., Mann, D. J., Marshall, J. F., Martin, L. A., Martin, S. G., Macdougall, J. E., Miles, D. W., Miller, W. R., Morris, J. R., Moss, S. M., Mullan, P., Natrajan, R., O’Connor, J. P., O’Connor, R., Palmieri, C., Pharoah, P. D. P., Rakha, E. A., Reed, E., Robinson, S. P., Sahai, E., Saxton, J. M., Schmid, P., Smalley, M. J., Speirs, V., Stein, R., Stingl, J., Streuli, C. H., Tutt, A. N. J., Velikova, G., Walker, R. A., Watson, C. J., Williams, K. J., Young, L. S., & Thompson, A. M.
- Venue
- Breast Cancer Research
- Published
- 2013-10-01
- Volume
- 15
- Issue
- 5
- Pages
- R92-R92
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2095783009
- Cited by
- 421
- References
- 379
- FWCI
- 12.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.